Assessment of Body Composition in Oncology: Moving Research into Practice (Week 4 Lecture 1) Flashcards

1
Q

What is body composition?

A

Refers to the amount and distribution of what our bodies are made up of
* Assessment techniques vary by compartments being measured

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the body composition levels?

A
  • atomic
  • molecular
  • cellular
  • tissues
  • whole body
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What factors influence body composition?

A
  • genetics
  • sex
  • race
  • growth, pregnancy
  • agin
  • injury
  • illness, disease, and treatment
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Why do we want to measure body composition

A
  • independently influences health
  • prognostic of clinical outcomes
  • Monitor changes associated with dieases [how you come in effects how well you do]
  • assess effectiveness of interventions
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is skeletal muscle a criterion for?

A
  • malnutrition
  • sarcopenia
  • cachexia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Comparison of body comp assessment tools

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What does choice of method depend on?

A
  • intended purpose
  • patient population
  • required accuracy
  • precision
  • availability
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

precision vs. accuracy

A
  • accuracy is closeness of the measurement to the true value
  • precision is the closeness of measurements to each other
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Consensus definition of cancer associated malnutrition

A
  • A multifactorial syndrome of involuntary weight loss (clinical presentation)
  • characterized by an ongoing loss of skeletal muscle mass (with or without loss of fat mass) (clinical presentation)
  • Due to a variable combination of reduced food intake and abnormal metabolism (etiology)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the primary use(s) of CT scans in oncology?

A
  • Determine the size, shape, and location of tumour (staging)
  • Determine cancer spread to nearby organs and tissues (staging)
  • guide biopsies, and delivery of local treatment
  • Plan for delivery of radiation or surgery
  • Determine the effectveiness of cancer treatment (compare size of tumour before, during, and after treatment)
  • Monitor for recurrence after treatment completed
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the use of CT scans for body composition?

A

CT scans are acquired for diagnosis and treatment; never for the sole purpose of assessing body composition
* High risk with radiation
* Costs a lot of resources

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

How does CT work?

A

X-rays are attenuated (i.e. absorbed) differently by different body tissues as they pass through and exit the body
* The denser the body tissue the more X-ray energy is absorbed which is referred to as tissue radiodensity (relative inability of X-rays to pass through through a particular material or tissue)
* Taking many measurements from many angles (A full rotation of the x-ray), the different tissue radiodensities are composed as grey scale cross-sectional image using a computer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How is tissue radiodensity expressed?

A

Hounsfield Units (HU)
* Quantitative scale for describing the radiodensity of different tissues
* different shades of grey represent tissues with different radiodensities
* internal organ will attenuate similar to skeletal muscle so need to know how to differentiate between them

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How was CT for body composition assessment validated?

A

Took skeletal muscle measurements from cross-sectional area of cadaver with CT (and MRI) and validated it with physical measurement.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What CT slice is used to estimate full body composition?

A

Cross-sectional image at L3
* Best associated to whole body for adipose tissue and skeletal muscle

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What tissues are quantified for a body composition assessment?

A

Adipose tissue
* Visceral adipose tissue (around organs)
* subcutaneous adipose tissue (under skin)

Skeletal muscle
* rectus abdominus
* internal obliques
* external obliques
* transverse abdominus
* psoas
* quadratus lumborum
* lattismus dorsi
* paraspinal (multfidus, iliocostalis, longissimus)

sagittal view

17
Q

How does CT compare to DEXA?

A

High correlation but CT provides more information about specific fat tissues and fat-free tissues

18
Q

What is myosteatosis?

A

fat infiltration to muscle
* Not really representive of fat in muscle on CT since it is marbled but does tell us about the radiodensity of the muscle → muscle that has low radiodensity is less healthy it is muscle attenuating more like fatty tissue and so quality is not as good.
* multi factorial (T2D, sedentary, HD/ pulmonary conditions)

19
Q

What data output is retrieved from the CT for body composition?

A

Cross-sectional areas (cm2)
* skeletal muscle
* visceral adipose tissue
* subcutaneous adipose tissue
* intra-muscular adipose tissue

Tissue radiodensity (HU)
* skeletal muscle
* visceral adipose tissue
* subcutaneous adipose tissue

20
Q

How is CT used in a research setting?

A
  • To describe variability in body composition
  • To identify at risk body composition body types
  • To predict clinical outcomes
  • To monitor changes over time
21
Q

How do clinical outcomes differ by oncology setting?

A
  • Early stage cancer: treatment setting = surgery
  • Advanced stage cancer: treatment setting = medicial oncology
22
Q

What are the associations between body composition and clinical outcomes?

A

Uses stats to define the association with defined cut-offs
* postop/surgical complications
* LOS
* need for rehab care
* 30-day mortality
* readmission
* cancer/tumor recurrence
* treatment toxicity
* physical funcrtion
* QOL
* mortality

23
Q

What body compositions are considered at risk?

A
  • sarcopenic obesity: ↑ mortality, ↑ surgical complications
  • low skeletal muscle mass: ↑ mortality
  • Myosteatosis: ↑ mortality
  • visceral obesity: ↑ LOS, ↑ operative time
24
Q

what types of cutoffs are used for body composition from CT to assess clincal outcomes?

A

cross-sectional areas (cm2; cm2/cm2)
* low skeletal muscle → sarcopenia
* high visceral adipose tissue → visceral obesity

Tissue-specific radiodensity (HU)
* low skeletal muscle radiodensity →myosteatosis

25
Q

How does sarcopenic-obesity effect mortality?

A

sarcopenia significantly associated with overall survival
* defined sex-specific cutoffs for CT-defined sarcopenia as <52.4 cm2/cm2 for men & <38.5 cm2/cm2 for women
* defined an at-risk body composition phenotype as sarcopenia obese

26
Q

What is sarcopenic obesity?

A

Hidden muscle wasting and its impact for survival and complications of cancer therapy

27
Q

Prevalence of sarcopenic obesity?

A
  • 9% overall prevalence in advanced solid tumor patients (range 2-15%)
  • 1 in 4 obese patients are sarcopenic (range 6-39%)
28
Q

What are sarcopenic obese at risk for?

A
  • ↑ mortality
  • ↑ surgical complications
29
Q

BMI cut-offs for CT-defined low skeletal muscle mass associated with decreased overall survival

A

males
* BMI <25; SMI <43 cm2/m2
* BMI >25; SMI <43 cm2/m2

females
* SMI <41 cm2/m2

30
Q

How

How does mortality change with cancer type wtih low skeletal muscle mass?

A

increases risk in all types of cancer (colorectal, hepatocellular, pancreatic, gastroesophageal were studied)
* prevalent range 15-50%

31
Q

What is associated with with mortality acorss cancer types?

A
  • low skeletal muscle mass
  • myosteatosis
  • sarcopenic obese
32
Q

How do myosteatosis, visceral obesity & sarcopenia overlap?

A

Predicts 8 different adverse body composition phenotypes
* 4% have all 3
* 72% have one of these phenotypes
* those with visceral tissue had readmission to the hospital

33
Q

How does muscle mass diminish with healthy aging?

A

0.5-1%/ year beginning around age 40 (8%/decade), and accelerates after 70 to about 15%/decade

34
Q

How might muscle mass diminish in cancer patients?

A

study done with advanced cervical cancer saw median loss of 5% in 200 days
* 5 years worth of muscle loss

35
Q

What might be a better tool in identifying low muscle mass for cancer malnutrition instead of an SGA?

A

CT scan to get more precise skeletal muscle measurements

36
Q

What indications of the CT scan were benefical for RDs in their practice?

A
37
Q

How has knowing about a patients skeletal muscle changed RDs protein reccomendations?

A